Chengdu Huasun Group Inc., Ltd. (SZSE: 000790) announced yesterday that its biological tech subsidiary has been supported by China in doing an anticancer research. The research is concerned with the utilization of Iodine [131I] Metuximab ...
Tags: Health, Medicine, Anticancer Product